Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT-2: Avatrombopag for Thrombocytopenia in CLD
NCT01976104Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of avatrombopag in Thrombocytopenia, sponsored by Eisai Co., Ltd.. Started Nov 2013; status: completed.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01976104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01976104.